Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma.
Authors: Christopeit M; Department of Medicine IV, Oncology/Hematology, University Hospital Halle Saale, Halle Saale, Germany., Lenz G, Forstpointner R, Bartelheim K, Kühnbach R, Naujoks K, Schalhorn A
Source: Chemotherapy [Chemotherapy] 2008; Vol. 54 (4), pp. 309-14. Date of Electronic Publication: 2008 Aug 14.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0144731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9794 (Electronic) Linking ISSN: 00093157 NLM ISO Abbreviation: Chemotherapy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1421-9794
DOI:10.1159/000151352